Fonte: European Journal of Heart Failure. Unidade: FMRP
Assuntos: ANEMIA, CARDIOPATIAS, COMORBIDADE, IDOSOS, CAUSA DA MORTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MCMURRAY, John J. V. et al. Baseline characteristics of patients in the reduction of events with darbepoetin alfa in heart failure trial (RED-HF). European Journal of Heart Failure, v. 15, n. 3, p. 334\2013341, 2013Tradução . . Disponível em: https://doi.org/10.1093/eurjhf/hfs204. Acesso em: 25 ago. 2024.APA
McMurray, J. J. V., Anand, I. S., Diaz, R., Maggioni, A. P., O’Connor, C., Pfeffer, M. A., et al. (2013). Baseline characteristics of patients in the reduction of events with darbepoetin alfa in heart failure trial (RED-HF). European Journal of Heart Failure, 15( 3), 334\2013341. doi:10.1093/eurjhf/hfs204NLM
McMurray JJV, Anand IS, Diaz R, Maggioni AP, O’Connor C, Pfeffer MA, Solomon SD, Tendera M, Veldhuisen DJ van, Albizem M, Cheng S, Scarlata D, Swedberg K, Young JB, Simões MV. Baseline characteristics of patients in the reduction of events with darbepoetin alfa in heart failure trial (RED-HF) [Internet]. European Journal of Heart Failure. 2013 ; 15( 3): 334\2013341.[citado 2024 ago. 25 ] Available from: https://doi.org/10.1093/eurjhf/hfs204Vancouver
McMurray JJV, Anand IS, Diaz R, Maggioni AP, O’Connor C, Pfeffer MA, Solomon SD, Tendera M, Veldhuisen DJ van, Albizem M, Cheng S, Scarlata D, Swedberg K, Young JB, Simões MV. Baseline characteristics of patients in the reduction of events with darbepoetin alfa in heart failure trial (RED-HF) [Internet]. European Journal of Heart Failure. 2013 ; 15( 3): 334\2013341.[citado 2024 ago. 25 ] Available from: https://doi.org/10.1093/eurjhf/hfs204
